PTPRC and neoplasm: Furthermore, a substantial enhancement of innate effector cells (expressing CD45+CD11b+Ly6G+) and reduced the concentration of suppressive myeloid cells (expressing CD11b+CD11c+) were detected on phenotypic studies of tumor immune infiltrates in mice with favorable gut microbiota [27].